Trials / Completed
CompletedNCT01541254
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Microvention-Terumo, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and probable benefit of the Low-profile Visualized Intraluminal Support (LVIS™ and LVIS™ Jr.)devices from MicroVention, Inc. when used to facilitate endovascular coiling of unruptured wide-neck intracranial aneurysms with bare platinum embolization coils.
Detailed description
With the stent-assisted technique to treat wide neck intracranial aneurysms, the neurovascular stent is placed across the aneurysm neck, to act as a bridge to prevent coils from protruding into the parent artery. Stenting may allow to more safely achieve a higher packing density of coils. These effects may improve the rates of complete aneurysm occlusion and enhance the durability of the coiling treatment.The LVIS™ device manufactured by MicroVention, Inc. has a braided design which may provide superior conformability and parent artery apposition, as well as a more reliable continuous and uniform neck bridging than other neurovascular stents.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Low profile Visualized Intraluminal Device (LVIS and LVIS Jr.) | Low profile Visualized Intraluminal Device (LVIS and LVIS Jr.) |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2012-02-29
- Last updated
- 2025-07-01
- Results posted
- 2014-09-15
Locations
6 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT01541254. Inclusion in this directory is not an endorsement.